| Literature DB >> 35540151 |
Intidhar Bkhairia1, Sabah Dhibi2,3, Rim Nasri1, Abdelfettah Elfeki2, Najla Hfaiyedh2,3, Ibtissem Ben Amara4, Moncef Nasri1.
Abstract
This study was undertaken to examine the hepatoprotective, antioxidant, and DNA damage protective effects of protein hydrolysates from Liza aurata, against paracetamol overdose induced liver injury in Wistar rats. L. aurata protein hydrolysates (LAPHs) were mainly constituted by glutamic acid (Glu) and glutamine (Gln) and lysine (Lys). In addition, they contained high amounts of proline (Pro), leucine (Leu) and glycine (Gly). The molecular weight distribution of the hydrolysates was determined by size exclusion chromatography, which analyzed a representative hydrolysate type with a weight range of 3-20 kDa. The hepatoprotective effect of LAPHs against paracetamol liver toxicity was investigated by in vivo assay. Rats received LAPHs daily by gavage, for 45 days. Paracetamol was administrated to rats during the last five days of treatment by intraperitoneal injection. Paracetamol overdose induced marked liver damage in rats was noted by a significant increase in the activities of serum aspartate amino transferase (AST) and alanine amino transferase (ALT), and oxidative stress which was evident from decreased activity of the enzymatic antioxidants (superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx)), and level of glutathione (GSH), and increased concentration of lipid peroxidation products (MDA). Furthermore, paracetamol increased the DNA damage with liver histopathological changes. LAPH pretreatment significantly attenuated paracetamol-induced hepatotoxic effects, including oxidative damage, histopathological lesions, and apoptotic changes in the liver tissue. Interestingly, LAPHs restored the activities of antioxidant enzymes and the level of GSH, ameliorated histological and molecular aspects of liver cells. The present data suggest that paracetamol high-dose plays a crucial role in the oxidative damage and genotoxicity of the liver and therefore, some antioxidants such us LAPHs might be safe as hepatoprotectors. Altogether, our studies provide consistent evidence of the beneficial effect of LAPHs on animals treated with a toxic dose of paracetamol and might encourage clinical trials. This journal is © The Royal Society of Chemistry.Entities:
Year: 2018 PMID: 35540151 PMCID: PMC9081614 DOI: 10.1039/c8ra02178c
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Composition of basic food (Society of Animals Nutrition “SNA”, Sfax, Tunisia). This food consists of corn, soya, VMC (vitamins minerals compound) with the following characteristics
|
| |
| Moisture (maximal) | 14 |
| Fibers (maximal) | 5 |
| Proteins (minimal) | 18 |
| Fat (maximal) | 3 |
| Ash (maximal) | 13.5 |
| Carbohydrate | 46.5 |
| Calorific value (kcal kg−1) | 2846 |
|
| |
| Methionine | 0.36 |
| Cysteine | 0.26 |
| Threonine | 0.62 |
| Tryptophan | 0.2 |
|
| |
| Manganese | 80 |
| Fer | 48 |
| Cuivre | 18 |
| Zinc | 64 |
| Selenium | 0.28 |
| Cobalt | 0.2 |
| Iode | 2 |
|
| |
| Vitamine A | 11 200 |
| Vitamine D3 | 2800 |
| Vitamine H | 25 |
| Antioxidant (BHA–BHT) | 100 |
Fig. 1In vitro study. (A) Molecular weight distribution of LAPHs by SEC chromatogram. (B) Stability of LAPHs as monitored by β-carotene bleaching assay. Values are means ± stability of LAPHs of three determinations. (C) Protective effect of LAPHs on Cu2+/H2O2 induced protein oxidation. BSA samples were separated by SDS-PAGE and stained with Coomassie brilliant blue R-250 (upper bands). Each value is expressed vs. control (native BSA). Cu2+/H2O2 treatment (Treat, BSA with Cu2+/H2O2 in the absence of LAPHs). *p < 0.01 when the band of native BSA is compared to the band of BSA with Cu2+/H2O2,+p < 0.01 when the band of BSA incubated in the presence of protein hydrolysates and Cu2+/H2O2 are compared to the band of BSA + Cu2+/H2O2 band.
Molecular weight distribution of LAPHs calculated from the area under curves of the profiles obtained by SEC analysisa
| SEC distribution | ||||||
|---|---|---|---|---|---|---|
| Mass (kDa) | >20 | 20–10 | 10–5 | 5–3 | <5 | <3 |
| PH-LA | 9.16 | 12.61 | 20.53 | 23.61 | 57.7 | 34.09 |
| PH-TR | 9.27 | 12.05 | 37.1 | 11.66 | 41.58 | 29.92 |
| PH-ES | 6.7 | 16.43 | 27.64 | 11.52 | 49.23 | 37.9 |
| PH-A26 | 11.13 | 18.14 | 28.67 | 19.76 | 42.06 | 22.3 |
| PH-A2 | 16.29 | 20.48 | 27.92 | 20.13 | 35.31 | 15.18 |
SEC method was used to calculate the MW distribution of the LAPHs.
Amino acid composition (%) of the LAPHs
| Amino acids | PH-A2 | PH-A26 | PH-LA | PH-TR | PH-ES |
|---|---|---|---|---|---|
|
| |||||
| Aspartic acid and asparagine (Asp and Asn) | 9.84 ± 0.10b | 10.02 ± 0.80a | 10.06 ± 0.06a | 9.92 ± 0.80a | 10.13 ± 1.10a |
| Glutamic acid and glutamine (Glu and Gln) | 15.75 ± 1.00d | 16.80 ± 0.10a | 16.18 ± 0.20b | 15.2 ± 0.35e | 16.00 ± 0.71c |
| Serine (Ser) | 3.93 ± 0.01d | 4.39 ± 0.10a | 4.01 ± 0.19c | 3.83 ± 0.21e | 4.19 ± 0.30b |
| Glycine (Gly) | 7.41 ± 0.02d | 8.33 ± 0.11a | 8.09 ± 0.20b | 6.63 ± 0.01e | 7.95 ± 0.42c |
| Histidine | 2.04 ± 0.02c | 2.15 ± 0.12b | 2.20 ± 0.27a | 1.84 ± 0.02d | 2.26 ± 0.61a |
| Arginine (Arg) | 5.01 ± 0.01a | 4.02 ± 0.13b | 2.18 ± 0.31e | 4.21 ± 0.10c | 3.95 ± 0.10d |
| Threonine | 4.48 ± 0.20d | 5.00 ± 0.14b | 5.40 ± 0.35a | 4.10 ± 0.32e | 4.89 ± 0.30c |
| Tyrosine (Tyr) | 2.48 ± 0.52b | 2.42 ± 0.15b | 2.60 ± 0.39a | 2.40 ± 0.02b | 2.63 ± 0.95a |
| Lysine | 11.09 ± 0.03b | 8.02 ± 0.16e | 10.45 ± 0.43c | 16.67 ± 1.23a | 8.91 ± 0.10d |
|
| |||||
| Proline (Pro) | 8.81 ± 0.00b | 8.73 ± 0.17c | 8.26 ± 0.47d | 8.27 ± 0.10d | 8.94 ± 0.14a |
| Alanine (Ala) | 7.04 ± 0.00b | 7.02 ± 0.17b | 7.08 ± 0.51b | 6.41 ± 0.10c | 7.87 ± 0.00a |
| Valine | 4.56 ± 0.00b | 4.53 ± 0.18b | 4.86 ± 0.55a | 4.23 ± 0.21c | 4.51 ± 0.1b |
| Methionine | 2.81 ± 0.00c | 2.97 ± 0.19b | 3.04 ± 0.59a | 2.51 ± 0.15d | 3.03 ± 0.14ab |
| Isoleucine | 4.18 ± 0.05c | 4.47 ± 0.20b | 4.65 ± 0.63a | 4.56 ± 0.61a | 4.42 ± 0.16b |
| Leucine | 7.31 ± 0.10d | 7.58 ± 0.21c | 7.87 ± 0.68b | 6.28 ± 0.13a | 7.44 ± 0.94c |
| Phenylalanine | 3.26 ± 0.10b | 3.50 ± 0.72a | 3.01 ± 0.72c | 2.90 ± 0.75d | 2.85 ± 0.27d |
| Total | 100 | 100 | 100 | 100 | 100 |
Essential amino acids. HAA: hydrophobic amino acid. Values are given as mean SD from triplicate determinations (n = 3), a,b,c,d,e in the same line indicate significant differences (p < 0.01).
Fig. 2In vivo study. (A) DNA fragmentation assay. Lane 1: DNA of control group. Lane 2: DNA of paracetamol treated group. Lane 3, 4, 5, 6 and 7: DNA from, PH-TR, PH-A26, PH-LA, PH-ES and PH-A2 treated rats, respectively. (B) Effect of LAPHs on liver MDA content in rats subjected to paracetamol-induced hepatotoxicity. Data are expressed as means ± SM (n = 6). *p < 0.01 when the control group is compared to the paracetamol group; +p < 0.01 when the treated protein hydrolysates groups are compared to the paracetamol group. (C) Effect of LAPHs on liver GPx, CAT, and SOD activities in rats subjected to paracetamol-induced hepatotoxicity. Data are expressed as means ± SM (n = 6). *p < 0.01 when the control group is compared to the paracetamol group; +p < 0.01 when the treated protein hydrolysates groups are compared to the paracetamol group. (D) Effect of LAPHs on liver GSH content in rats subjected to paracetamol-induced hepatotoxicity. Data are expressed as means ± SM (n = 6). *p < 0.01 when the control group is compared to the paracetamol group; +p < 0.01 when the treated protein hydrolysates groups are compared to the paracetamol group.
Influence of LAPHs on AST, ALT level in rat serum in a model of paracetamol induced hepatotoxicitya
| Groups | AST (U L−1) | ALT (U L−1) | Glucose (mmol L−1) | LDH (U L−1) | ALP (U L−1) |
|---|---|---|---|---|---|
| Control | 196 ± 13.3b | 88.32 ± 3.21d | 5.41 ± 0.39de | 1006 ± 24ef | 341 ± 27ef |
| Paracetamol (P) | 269.15 ± 27.32a | 151.3 ± 6.35a | 9.45 ± 0.41a | 1563 ± 38a | 586 ± 27a |
| PH-LA/(P) | 177.96 ± 15.32c | 111.32 ± 7.32bc | 6.34 ± 0.47c | 1241 ± 17b | 407 ± 8.0bc |
| PH-TR/(P) | 145.32 ± 18.32e | 120.96 ± 6.18b | 7.21 ± 0.12b | 1205 ± 21bc | 413 ± 15b |
| PH-ES/(P) | 156.89 ± 11.66de | 117.69 ± 5.32b | 6.89 ± 0.61bc | 1102 ± 33d | 397 ± 19c |
| PH-A2/(P) | 166.32 ± 14.32d | 99.64 ± 4.62c | 5.21 ± 0.14e | 1086 ± 27de | 388 ± 10cd |
| PH-A26/(P) | 198.25 ± 15.26b | 89.34 ± 2.94d | 5.91 ± 0.36cd | 1074 ± 35ef | 361 ± 22e |
AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; glucose; ALP, alkaline phosphatase; PH-LA, PH-TR, PH-ES, PH-A2 and PH-A26: protein hydrolysate obtained with crude enzyme from L. aurata, trypsin, esperase, Pseudomonas aeruginosa A2 and Bacillus subtilis A26 respectively. Data expressed as mean ± SD in each group (n = 6). a,b,c,d,e,f The means with no common superscripts differ significantly (p < 0.01).
Influence of LAPHs on hematologic parameters in rat liver in a model of paracetamol-induced hepatotoxicitya
| Groups | RBC (106 μl−1) | Ht (%) | Hb (g dl−1) | CMV (fentolitre) | WBC (103 μl−1) | Plt (103 mm−3) |
|---|---|---|---|---|---|---|
| Control | 8.65 ± 0.37a | 40.7 ± 0.86a | 13.7 ± 0.95a | 55.1 ± 0.85g | 10.32 ± 0.5g | 645 ± 22.3e |
| Paracetamol (P) | 5.23 ± 0.47e | 36.6 ± 0.8d | 9.6 ± 0.9e | 22.1 ± 0.97f | 13.56 ± 0.13a | 1234 ± 31.6a |
| PH-LA/(P) | 6.98 ± 0.44d | 38.6 ± 0.57b | 10.32 ± 0.81d | 38.9 ± 0,67e | 11.62 ± 0.48c | 820 ± 43.6g |
| PH-TR (P−1) | 7.31 ± 0.63c | 40.5 ± 0.35a | 10.97 ± 0.68c | 40.1 ± 0.69c | 11.32 ± 0.72d | 836 ± 63.1f |
| PH-ES (P−1) | 8.07 ± 0.42b | 37.6 ± 0.97c | 12.95 ± 0.67a | 47.32 ± 0,37a | 10.67 ± 0.35f | 969 ± 38.6c |
| PH-A2/(P) | 8.32 ± 0.19a | 39.6 ± 0.81ab | 10.99 ± 0.63c | 39.6 ± 0,77d | 12.36 ± 0.29b | 987 ± 55.32b |
| PH-A26/(P) | 8.04 ± 0.72ab | 38.1 ± 0.44bc | 11.27 ± 0.52b | 45.12 ± 0.15b | 10.93 ± 0.77e | 852 ± 34.33d |
RBC, red blood cell; WBC, white blood cell; Ht, hematocrit; Hb, hemoglobin; CMV, mean cell volume; Plt, platelets. Data are expressed as mean ± SD in each group (n = 6). a,b,c,d,e,f,g The means with no common superscripts differ significantly (p < 0.01)
Fig. 3Effects protein hydrolysates from Liza aurata muscle on the liver histological changes in paracetamol-induced hepatotoxicity in rats. Microscopic observations of rat liver sections (A–G: 200×). (A) Control group showing normal hepatic architecture of the central vein (cv) and surrounding hepatocytes (h); (B) paracetamol-treated group showing cortico-inflammatory lesions, congestion and dilation of the central vein, with centrilobular necrosis in the surrounding parenchyma; (C) PH-A2/paracetamol-treated group; (D) PH-ES/paracetamol-treated group; (E) PH-LA/paracetamol-treated group; (F) PH-A2/paracetamol-treated group; (G) PH-A26/paracetamol-treated group.